Search filters

List of works by René-Olivier Casasnovas

"Staging, restaging and treatment response assessment" in lymphomas: what we should know.

scientific article published on 21 December 2017

18F-FDG PET Dissemination Features in Diffuse Large B-Cell Lymphoma Are Predictive of Outcome

scientific article published on 14 June 2019

A controlled trial of the tolerance of amphotericin B infused in dextrose or in Intralipid in patients with haematological malignancies

scientific article published on 01 March 1994

A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC network study

scientific article published on 17 May 2019

A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts.

scientific article published on 9 September 2016

A tumor volume and performance status model to predict outcome prior to treatment in diffuse large B-cell lymphoma

scientific article published in 2022

A weekly regimen with dose escalation of doxorubicin for patients with advanced Hodgkin's lymphoma: results of a phase II study of the Groupe d'Etudes des Lymphomes de l'Adulte (GELA)

scientific article published on 01 April 2007

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.

scientific article

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial.

scientific article

Adrenal lymphoma: presentation, management and prognosis.

scientific article

An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.

scientific article published on 7 May 2013

Antibody-Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review.

scientific article published on 20 March 2018

Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC.

scientific article published on 16 August 2013

BET Family Protein BRD4: An Emerging Actor in NFκB Signaling in Inflammation and Cancer.

scientific article published on 6 February 2018

Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies.

scientific article published on 22 August 2016

Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma

scientific article

Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma

scientific article published on 9 May 2014

Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers

scientific article published on 17 January 2020

Bendamustine-based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers.

scientific article published on 23 February 2018

C-H activation in pyridoxal-5'-phosphate Schiff bases: the role of the imine nitrogen. A combined experimental and computational study

scientific article published on 27 August 2012

CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte.

scientific article

Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials.

scientific article published on 22 October 2015

Classical Hodgkin's lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant

scientific article

Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era

scientific article published on 30 January 2020

Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B.

scientific article

Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms.

scientific article published on 10 August 2012

Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T-cell lymphoma

scientific article published on 30 May 2019

Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment

scientific article published on 14 February 2017

Controversies in the Treatment of Classical Hodgkin Lymphoma

scientific article published on 02 October 2018

Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study.

scientific article published on 17 December 2013

Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohorts.

scientific article

De-escalation chemotherapy and hematological profiles in patients with advanced Hodgkin's lymphoma.

scientific article

Diagnosis of disseminated toxoplasmosis by PCR analysis of ascitic fluid in a patient with haematologic malignancy

scientific article published on 01 April 1998

Diagnostic value of serum IL-6 level in monoclonal gammopathies

article

Dobutamine Stress Echocardiography Identifies Anthracycline Cardiotoxicity

scientific article published on 01 September 2000

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial.

scientific article published on 9 April 2013

Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma

scientific article published on 26 September 2019

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction

scientific article published on 04 July 2019

EZH2 alterations in follicular lymphoma: biological and clinical correlations.

scientific article

Early 18F-FDG PET/CT response predicts survival in Relapsed/Refractory Hodgkin Lymphoma treated with Nivolumab

scientific article published on 18 October 2019

Early Interim PET Scans in Diffuse Large B-Cell Lymphoma: Can There Be Consensus About Standardized Reporting, and Can PET Scans Guide Therapy Choices?

scientific article published on September 1, 2012

Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

scientific article published in June 2017

Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study

scientific article published on 06 November 2008

Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin's disease: retrospective analysis of 158 cases from the French registry.

scientific article published on April 1998

Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte [...]

scientific article

Efficacy and tolerance of an amphotericm B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients

scientific article published on 01 January 1993

Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: a randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

scientific article published on 25 December 2012

Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centers

scientific article published on 08 June 2018

Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.

scientific article published on 25 April 2016

Emulsion of amphotericin B in Intralipid 20%: in vitro and in vivo efficacy

scientific article published on May 1, 1992

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA

scientific article published on 22 July 2021

Escalated BEACOPP in advanced Hodgkin's lymphoma

scientific article published on 04 April 2012

Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA)

scientific article published on 21 September 2015

Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial.

scientific article published on 14 February 2012

FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study

scientific article published on 12 July 2017

Factors predictive of early death in patients receiving high-dose CHOP (ACVB regimen) for aggressive non-Hodgkin's lymphoma: a GELA study.

scientific article published in July 2002

Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study

scientific article published on 02 July 2019

FcgammaRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP).

scientific article published in December 2004

Feasibility of using quinine, a potential multidrug resistance-reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia.

scientific article published on November 1992

First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin's lymphoma.

scientific article published on 28 November 2016

Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.

scientific article

Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial.

scientific article published on 5 November 2012

Good clinical practice recommendations for the use of PET/CT in oncology

scientific article published on 21 October 2019

Hematological cancer: Localized non-bulky Hodgkin lymphoma--future questions.

scientific article published on 31 January 2012

High Concentrations of Intrathecal Interleukin-6 in Human Bacterial and Nonbacterial Meningitis

scientific article published on August 1, 1992

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

scientific article published on 01 April 2020

High- and low-spin Fe(III) complexes of various AGE inhibitors

scientific article published on 13 March 2012

High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma

scientific article published on 28 May 2015

Hodgkin's lymphoma: better outcomes with fewer drugs?

scientific article published on 22 December 2014

Immunological classification of acute myeloblastic leukemias: relevance to patient outcome

scientific article published on 01 March 2003

Immunophenotype in erythroleukemia secondary to myelodysplastic syndrome

scientific article published on 01 August 1992

Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients

article

Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and G

scientific article published on 29 October 2012

Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study.

scientific article

Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery

scientific article published on 01 January 1997

Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia

scientific article published on 01 January 2001

Influence of Software Tool and Methodological Aspects of Total Metabolic Tumor Volume Calculation on Baseline [18F]FDG PET to Predict Survival in Hodgkin Lymphoma

scientific article published on 16 October 2015

Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CT.

scientific article

Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA

scientific article published on 21 March 2016

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.

scientific article

Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.

scientific article published on 14 April 2008

Interim 18F-FDG PET SUVmax reduction is superior to visual analysis in predicting outcome early in Hodgkin lymphoma patients.

scientific article published on 24 February 2014

Interim PET in Hodgkin Lymphoma: Is It So Useless?

scientific article published on 02 March 2017

Interim PET-driven strategy in de novo diffuse large B-cell lymphoma: do we trust the driver?

scientific article

Invasive pulmonary aspergillosis in neutropenic patients. Analysis of a series of 36 cases: contribution of thoracic scanners and itraconazole

scientific article published on January 1995

Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?

scientific article published on 12 April 2018

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.

scientific article published on 20 April 2017

Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

scientific article published on 08 November 2019

Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation

scientific article published on 10 May 2019

Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study

article

Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia.

scientific article published on 15 March 2018

Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

scientific article published on 13 November 2009

Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

scientific article published on 14 February 2006

Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies

scientific article published on 30 March 2015

M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH)

scientific article published on 10 October 2002

Management and outcome of primary CNS lymphoma in the modern era: An LOC network study

scientific article published on 06 January 2020

Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients

scientific article

Minimally differentiated acute myeloid leukemia (AML-MO) with lymphoid presentation at relapse: a case report

scientific article published on 01 October 2001

Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome

scientific article published on 18 December 2008

Nasopharyngeal lymphomas: further evidence for a natural killer cell origin.

scientific article published on August 1996

New therapy outlooks in Hodgkin lymphoma

scientific article published on 11 January 2017

No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial

scientific article

Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study

scientific article

Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma

scientific article published on 16 December 2021

Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study

scientific article published on 05 October 2018

Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.

scientific article published on 17 March 2014

Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern cART era.

scientific article published on 18 September 2017

PET-guided treatment in advanced-stage Hodgkin lymphoma: yes but which one?

scientific article published on 08 July 2019

PET-guided, BEACOPPescalated therapy in advanced Hodgkin lymphoma - Authors' reply

scientific article published on 01 April 2019

Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma.

scientific article published on 12 May 2007

Peripheral blood stem cell transplantation in a multiple myeloma patient with end-stage renal failure

scientific article published on July 1, 1997

Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma

scientific article published on 22 October 2015

Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis.

scientific article

Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma

scientific article published on 26 June 2012

Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes.

scientific article

Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.

scientific article

Phase II study of oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.

scientific article published on 19 January 2018

Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)

scientific article published on 12 December 2012

Plasma Cytokine and Soluble Receptor Signature Predicts Outcome of Patients With Classical Hodgkin's Lymphoma: A Study From the Groupe d'Etude des Lymphomes de l'Adulte

scientific article published on 26 March 2007

Polyvisceral arteritis in chronic graft-versus-host disease: antiphospholipid-negative thrombotic syndrome mimicking polyarteritis nodosa

scientific article published on 01 May 2002

Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies.

scientific article published on 20 February 2018

Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma patients.

scientific article published in September 2017

Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma

scientific article published on 6 June 2014

Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.

scientific article published on 6 March 2016

Prise en charge des cancers solides et des hémopathies malignes du sujet âgé : l'oncogériatrie, une discipline en devenir. Seconde partie : traitement des cancers solides (partie 2) et des hémopathies malignes du sujet âgé

scientific article published on 18 October 2004

Prognostic model for high tumor burden follicular lymphoma integrating baseline and end induction PET: a LYSA/FIL study.

scientific article published on 20 March 2018

Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project

scientific article published on 01 August 2019

Prognostic value of baseline metabolic tumor volume in early stage Hodgkin's lymphoma in the standard arm of H10 trial

scientific article published in February 2018

Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL).

scientific article published on 19 January 2016

Prophylactic fluconazole and Candida krusei infection

scientific article published on March 26, 1992

Quinine circumvents the doxorubicin resistance of a multidrug resistant human leukemic cell-line, K562/DXR

scientific article published on 01 January 1990

Radioimmunoassay for the measurement of serum IL-6 and its correlation with tumour cell mass parameters in multiple myeloma

scientific article published on 01 March 1992

Reply to H.J.A. Adams et al and E. Laffon et al

scientific article published on 28 December 2016

Reply to J. Wang et al

scientific article published on 12 February 2019

Reply to M. Lambertini et al

scientific article published on 28 November 2016

Reply to Z. Blumenfeld et al.

scientific article published on 3 September 2013

Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma

scientific article published on 2 February 2015

Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma.

scientific article published on 08 March 2017

Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study group

scientific article published on 17 November 2008

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.

scientific article published in September 2017

Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial.

scientific article

Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report

scientific article published in March 2017

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

scientific article

Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial

scientific article published on 10 June 2013

SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma

scientific article published on 25 April 2011

Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.

scientific article published on 27 April 2015

Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study.

scientific article published in April 2002

Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL)

scientific article published on 01 May 1992

Surgical management of invasive pulmonary aspergillosis in neutropenic patients

scientific article published on 01 November 1997

Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.

scientific article

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study

scientific article published on 24 July 2019

Systemic mast cell disease associated with hairy cell leukaemia

scientific article published on 01 May 1997

TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis

scientific article published on 01 August 2004

The 8p12 myeloproliferative disorder. t(8;19)(p12;q13.3): a novel translocation involving the FGFR1 gene

scientific article published on 01 November 2000

The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registry

scientific article published on 20 November 2014

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale

scientific article

The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL)

scientific article published on July 15, 1998

Theoretical calculations of stability constants and pKa values of metal complexes in solution: application to pyridoxamine-copper(II) complexes and their biological implications in AGE inhibition

scientific article published on 03 September 2013

Through the Glass Ceiling.

scientific article published on 25 January 2018

Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma

scientific article published on 01 April 2018

Unconventional immune-related phenomena observed using 18F-FDG PET/CT in Hodgkin lymphoma treated with anti PD-1 monoclonal antibodies

scientific article published on 19 March 2019

Upfront consolidation combining yttrium-90 ibritumomab tiuxetan and high-dose therapy with stem cell transplantation in poor-risk patients with diffuse large B cell lymphoma

scientific article published on 26 July 2014

Veratridine, but not elevated K+, inhibits excitatory amino acid transporter activity in rat hippocampal slices.

scientific article

[18F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives.

scientific article published on 18 May 2018

[Diagnostic imaging of lymphomas]

scientific article published on 01 January 2010

[Emergency lung resections for invasive aspergillosis in neutropenic patients]

scientific article published on 01 January 1995

[Extramedullary pancreatic localization of myeloma]

scientific article published on 01 January 1989

[The value of surgery in the treatment of invasive pulmonary aspergillosis in neutropenic patients]

scientific article published on 01 February 1998

[Update of the recommendations of good clinical practice for the use of PET in oncology]

scientific article published on 23 January 2019